← FDA Drug Approvals (Drugs@FDA)

INQOVI

NDA · New Drug Application · Sponsor: TAIHO ONCOLOGY · Approved 2020-07-07

Drug application

FDA Application #

NDA212576

Application type

New Drug Application

Brand name

INQOVI

Generic name

CEDAZURIDINE AND DECITABINE

Active ingredients

CEDAZURIDINE; DECITABINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAIHO ONCOLOGY

Manufacturer

Taiho Pharmaceutical Co., Ltd.

First approval

2020-07-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown